Are Covid-19 vaccines a sustainable business? Was Aduhelm an aberration? And what comes after Omicron?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Senior writer Helen Branswell joins us to discuss the latest twists in the pandemic, including rising case counts, next-generation vaccines, and the latest data from pediatric trials. We also dive into the latest news in the life sciences, including Moderna’s grand ambitions, Al Sandrock’s new job, and the next big FDA debate.
For more on what we cover, here’s the latest from Moderna; here’s more on next-generation vaccines; here’s the news on Sandrock; here’s where you can subscribe to the First Opinion Podcast; and here’s our complete coverage of the Covid-19 pandemic.
And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].
Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].
Create a display name to comment
This name will appear with your comment